Dr Reddy's, Sun Pharma, Aurobindo recall products in US

The company is also recalling another lot of sapropterin dihydrochloride for the same reason, it added. The USFDA said the drug maker initiated the Class I recall in the US on April 8 this year. As per the US health regulator, a Class I recall pertains to defective products that can cause serious health problems.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dcomHZX
via IFTTT